FDA Drugs recall ·
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets… recall
- Recall number
- D-0208-2025
- Date
- (initiated January 16, 2025)
- Company / brand
- Appco Pharma LLC
262 Old New Brunswick Rd Unit N, Piscataway, NJ, United States - Category
- Drugs › Class III
- Classification
- Class III
- Status
- Completed
- Units affected
- 1380 bottles
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Why was it recalled?
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot #: 2402101UR, Exp 02/28/2027
Distribution
Nationwide USA.
What does Class III mean?
Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).
Source: FDA (drugs), recall D-0208-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.